Cell Genesys, Inc. to Webcast Conference Call to Discuss Global Alliance Formed With Takeda Pharmaceutical Co. Ltd. for the Development and Commercialization of GVAX Immunotherapy for Prostate Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cell Genesys, Inc. (Nasdaq:CEGE - News), today announced that Cell Genesys management, including Stephen A. Sherwin, M.D., chairman and chief executive officer, Sharon E. Tetlow, senior vice president and chief financial officer, and Robert Tidwell, senior vice president of Corporate Development, will host a conference call today at 4:30 p.m. ET to discuss the global alliance formed with Takeda Pharmaceutical Company Limited for the development and commercialization of GVAX immunotherapy for prostate cancer.

Back to news